DAPK1 and gastric cancer: In contrast to s-DAPK-1, there is considerable evidence in the literature on microRNAs targeting DAPK-1; for example, DAPK-1 has been reported to be modulated by miR-26b-5p and miR-632 microRNAs in the contexts of intestinal ischemia and gastric cancer, respectively [65,66,67].